Wikiwand AI

Sofpironium bromide

Chemical compound From Wikipedia, the free encyclopedia

Sofpironium bromide, sold under the brand names Ecclock and Sofdra among others, is a medication used to treat hyperhidrosis (excessive sweating).[1] Sofpironium bromide is an anticholinergic agent that is applied to the skin.[1]

Trade namesEcclock, Sofdra, others
Other namesBBI-4000, BBI 4000
Quick facts Clinical data, Trade names ...
Sofpironium bromide
Clinical data
Trade namesEcclock, Sofdra, others
Other namesBBI-4000, BBI 4000
AHFS/Drugs.comMonograph
MedlinePlusa624052
License data
Routes of
administration
Topical
Drug classAnticholinergic
ATC code
Legal status
Legal status
Identifiers
  • [(3R)-1-(2-Ethoxy-2-oxoethyl)-1-methylpyrrolidin-1-ium-3-yl] (2R)-2-cyclopentyl-2-hydroxy-2-phenylacetate bromide
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC22H32BrNO5
Molar mass470.404 g·mol−1
3D model (JSmol)
  • CCOC(=O)C[N+]1(CC[C@H](C1)OC(=O)[C@@](C2CCCC2)(C3=CC=CC=C3)O)C.[Br-]
  • InChI=1S/C22H32NO5.BrH/c1-3-27-20(24)16-23(2)14-13-19(15-23)28-21(25)22(26,18-11-7-8-12-18)17-9-5-4-6-10-17;/h4-6,9-10,18-19,26H,3,7-8,11-16H2,1-2H3;1H/q+1;/p-1/t19-,22+,23?;/m1./s1
  • Key:FIAFMTCUJCWADZ-JOFREBOKSA-M
Close

It was approved for medical use in Japan in 2020,[2] and in the United States in June 2024.[1][3][4][5]

Medical uses

Sofpironium bromide is indicated for the treatment of primary axillary hyperhidrosis.[1]

Mechanism of action

The pharmacodynamics of sofpironium bromide are unknown.[1]

Society and culture

It was approved for medical use in Japan in November 2020,[6] and in the United States in June 2024.[1][7]

Brand names

Sofpironium bromide is the international nonproprietary name.[8]

It is sold under the brand name Ecclock in Japan and under the brand name Sofdra in the US.

References

Further reading

Related Articles

Timelines

Top Qs

Fact Checks